Azadeh Mary Afzali

DDS | Dentist



  
  946 Harlem Ave, Glenview
  Illinois, 60025-4275

  847-724-3969    847-724-3972 Maps & Directions
Azadeh Mary Afzali is a Glenview, Illinois based Dentist who is specialized in General Practice Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 946 Harlem Ave, Glenview. Patients can reach her at 847-724-3969.
Azadeh Mary Afzali is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Azadeh Mary Afzali speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Azadeh Mary Afzali
Specialization: Dentist
Gender:Female
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:946 Harlem Ave, Glenview,
Illinois, 60025-4275
Phone:847-724-3969
Fax:847-724-3972
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 6709148844
Enrollment ID: I20181127002951
NPI Number: 1275796237
NPI Enumeration Date: 09 Jul, 2008
NPI Last Update On: 12 Mar, 2018

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 946 Harlem Ave,
Glenview, Illinois
Zip: 60025-4275
Phone Number: 847-724-3969
Fax Number: 847-724-3972
Patients can reach Azadeh Mary Afzali at 946 Harlem Ave, Glenview, Illinois or can call to book an appointment on 847-724-3969. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: